Emma Beddowes

1.1k citations
12 papers · 295 indexed · h-index 8
Topics
Cancer Genomics and Diagnostics (3 papers)Advanced Breast Cancer Therapies (2 papers)Carcinogens and Genotoxicity Assessment (2 papers)

In The Last Decade

Emma Beddowes

12 papers receiving 289 citations

Peers

Emma Beddowes
Comparison fields: 5 of 79
  • Cancer Research 98
  • Molecular Biology 97
  • Pulmonary and Respiratory Medicine 66
  • Biotechnology 56
  • Oncology 43
Replace Mitsuya Ito with:
Mitsuya Ito Japan
Kim Zukowski United States
Ruisheng Yao United States
Yanqing Liu China
Mamoru Mutai Japan
Tokuo Sukata Japan
Zhi‐Tu Zhu China
Thai-Vu T. Ton United States
Yukitada Miyata Japan
Sisko Anttila Finland
Emma Beddowes relative to Mitsuya Ito Japan Mitsuya Ito's profile →
Citations per field
00.5×2.7×
Mitsuya Ito · 1×
Citations per year

Countries citing papers authored by Emma Beddowes

Since Specialization
Citations

This map shows the geographic impact of Emma Beddowes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Beddowes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Beddowes more than expected).

Fields of papers citing papers by Emma Beddowes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Beddowes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Beddowes. The network helps show where Emma Beddowes may publish in the future.

Co-authorship network of co-authors of Emma Beddowes

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Beddowes. A scholar is included among the top collaborators of Emma Beddowes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Beddowes. Emma Beddowes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 10
2 1
3 34
4 17
5 13
6 89
7 7
8 2
9
Characterization of antibody responses in malignant melanoma
1
10 39
11 80
12 2

About Emma Beddowes

Emma Beddowes is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 12 papers that have together received 295 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), Advanced Breast Cancer Therapies (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). The work is most often cited by research in Cancer Research (98 citations), Biotechnology (56 citations) and Pharmacology (25 citations). Emma Beddowes has collaborated with scholars based in United Kingdom, Netherlands and Spain. Frequent co-authors include James Kevin Chipman, Stephen P. Faux, Jason L. Parsons, Carlos Caldas, Meiling Gao, Stephen‐John Sammut, Pui Ying Chan, Bor-Wen Wu, Peter W. Szlosarek and James Spicer. Their work appears in journals such as Journal of Clinical Oncology, Annual Review of Biochemistry and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026